Cellular prion protein prevents brain damage after encephalomyocarditis virus infection in mice

Archives of Virology

Volumn 153, Issue 6, 2008, Pages 1007-1012

  Nasu Nishimura, Y ^a   Taniuchi, Y ^a   Nishimura, T ^a   Sakudo, A ^a,b   Nakajima, K ^a   Ano, Y ^a   Sugiura, K ^c   Sakaguchi, S ^d   Itohara, S ^e   Onodera, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c FOOD AND AGRICULTURAL MATERIALS INSPECTION CENTER   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL COUNT; CYTOLOGY; ENCEPHALOMYOCARDITIS VIRUS; GENETICS; HIPPOCAMPUS; INFLAMMATION; MICROGLIA; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; PRION; PYRAMIDAL NERVE CELL; VIROLOGY; VIRUS INFECTION;

ANIMALS; APOPTOSIS; CARDIOVIRUS INFECTIONS; CELL COUNT; ENCEPHALOMYOCARDITIS VIRUS; HIPPOCAMPUS; INFLAMMATION; MICE; MICE, KNOCKOUT; MICROGLIA; PRIONS; PRPC PROTEINS; PYRAMIDAL CELLS;

ENCEPHALOMYOCARDITIS VIRUS; MUS;

EID: 44449098030     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-008-0086-x     Document Type: Article

References (35)

1. Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, Marino S, Weissmann C, Aguzzi A (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379:339-343
2. Brown DR, Schmidt B, Kretzschmar HA (1996) A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture. Glia 18:59-67
3. Brown DR, Schmidt B, Kretzschmar HA (1996) Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380:345-347
4. Brown HR, Goller NL, Rudelli RD, Merz GS, Wolfe GC, Wisniewski HM, Robakis NK (1990) The mRNA encoding the scrapie agent protein is present in a variety of non-neuronal cells. Acta Neuropathol (Berl) 80:1-6
5. Beuler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-582
6. Caamano JH, Rizzo CA, Durham SK, Barton DS, Raventos-Suarez C, Snapper CM, Bravo R (1998) Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med 187:185-196
7. Cashman NR, Loertscher R, Nalbantoglu J, Shaw I, Kascsak RJ, Bolton DC, Bendheim PE (1990) Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 61:185-192
8. Dal-Pizzol F, Klamt F, Vianna MM, Schroder N, Quevedo J, Benfato MS, Moreira JC, Walz R (2000) Lipid peroxidation in hippocampus early and late after status epilepticus induced by pilocarpine or kainic acid in Wistar rats. Neurosci Lett 291:179-182
9. Hafiz FB, Brown DR (2000) A model for the mechanism of astrogliosis in prion disease. Molec Cell Neurosci 16:221-232
10. Halliwell B, Gutteridge JC (1999) Free radicals in biology and medicine. Oxford University Press, New York
11. Hayashi Y, Tomimatsu Y, Suzuki H, Yamada J, Wu Z, Yao H, Kagamishi Y, Tateishi N, Sawada M, Nakanishi H (2006) The intra-arterial injection of microglia protects hippocampal CA1 neurons against global ischemia-induced functional deficits in rats. Neuroscience 142:87-96
12. Keshet GI, Ovadia H, Taraboulos A, Gabizon R (1999) Scrapie-infected mice and PrP knockout mice share abnormal localization and activity of neuronal nitric oxide synthase. J Neurochem 72:1224-1231
13. Kitamura Y, Yanagisawa D, Inden M, Takata K, Tsuchiya D, Kawasaki T, Taniguchi T, Shimohama S (2005) Recovery of focal brain ischemia-induced behavior dysfunction by intracerebroventricular injection of microglia. J Pharmacol Sci 97:289-293
14. Klamt F, Dal-Pizzol F, Conte da Frota ML, Walz R, Andrades ME, da Silva EG, Brentani RR, Izquierdo I, Fonseca Moreira JC (2001) Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic Biol Med 30:1137-1144
15. Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S, Onodera T (1999) Prions prevent neuronal cell-line death. Nature 400:225-226
16. Manson J, West JD, Thomson V, McBride P, Kaufman MH, Hope J (1992) The prion protein gene: a role in mouse embryogenesis. Development 115:117-122
17. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8:121-127
18. Mizutani M, Hirasawa K, Takeda M, Doi K, Yukawa M, Matsumoto Y, Matsumoto Y, Onodera T (1996) Variation in serum creatine phosphokinase activity as indicated in two-phase EMC-D virus-induced myocarditis. Exp Animal 45:333-338
19. Moore RC, Melton DW (1997) Transgenic analysis of prion diseases. Molec Hum Reprod 3:529-544
20. Moser M, Colello RJ, Pott U, Oesch B (1995) Developmental expression of the prion protein gene in glial cells. Neuron 14:509-517
21. Nishida N, Tremblay P, Sugimoto T, Shigematsu K, Shirabe S, Petromilli C, Erpel SP, Nakaoke R, Atarashi R, Houtani T, Torchia M, Sakaguchi S, DeArmond SJ, Prusiner SB, Katamine S (1999) A mouse prion protein transgene rescues mice deficient for the prion protein gene from purkinje cell degeneration and demyelination. Lab Invest 79:689-697
22. Ohguchi A, Nakayama Y, Yasoshima A, Doi C, Mikami T, Uetsuka K, Nakayama H, Doi K (2006) Encepalomyocarditis virus-induced apoptosis and ultrastructural changes in the lacrimal and parotid glands of mice. Exp Mol Pathol 80:201-207
23. Onodera T, Sakudo A, Wu G, Saeki K (2006) Bovine spongiform encephalopathy in Japan: history and recent studies on oxidative stress in prion diseases. Microbiol Immunol 50:565-578
24. Roucou X, LeBlanc AC (2005) Cellular prion protein neuroprotective function: implications in prion diseases. J Molec Med 83:3-11
25. Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu K, Sugimoto T, Nakatani A, Kataoka Y, Houtani T, Shirabe S, Okada H, Hasegawa S, Miyamoto T, Noda T (1996) Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380:528-531
26. Sakudo A, Lee DC, Saeki K, Nakamura Y, Inoue K, Matsumoto Y, Itohara S, Onodera T (2003) Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line. Biochem Biophys Res Commun 308:660-667
27. Sakudo A, Nakamura I, Ikuta K, Onodera T (2007) Recent developments in prion disease research: diagnostic tools and in vitro cell culture models. J Vet Med Sci 69:329-337
28. Sakudo A, Onodera T, Ikuta K (2007) Prion protein gene-deficient cell lines: powerful tools for prion biology. Microbiol Immunol 51:1-13
29. Sakudo A, Onodera T, Suganuma Y, Kobayashi T, Saeki K, Ikuta K (2006) Recent advances in clarifying prion protein functions using knockout mice and derived cell lines. Mini Rev Med Chem 6:589-601
30. Schwarz EM, Badorff C, Hiura TS, Wessely R, Badorff A, Verma IM, Knowlton KU (1998) NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice. J Virol 72:5654-5660
31. Shafi R, Cerutis DR, Giron DJ (1993) Pathogenesis of the B variant of encephalomyocarditis virus. J Med Virol 40:193-199
32. Tanaka N, Sato M, Lamphier MS, Nozawa H, Oda E, Noguchi S, Schreiber RD, Tsujimoto Y, Taniguchi T (1998) Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 3:29-37
33. Tanji K, Saeki K, Matsumoto Y, Takeda M, Hirasawa K, Doi K, Matsumoto Y, Onodera T (1995) Analysis of PrPc mRNA by in situ hybridization in brain, placenta, uterus and testis of rats. Intervirology 38:309-315
34. Weissmann C, Aguzzi A (1999) Perspectives: neurobiology. PrP's double causes trouble. Science 286:914-915
35. Wong BS, Liu T, Li R, Pan T, Petersen RB, Smith MA, Gambetti P, Perry G, Manson JC, Brown DR, Sy MS (2001) Increased levels of oxidative stress markers detected in the brains of mice devoid of prion proteins. J Neurochem 76:565-572